Type III Humanized Recombinant Collagen: Why OTESALY Collagen Lift Is a Step Above Traditional Collagen Stimulators

The Collagen Crisis: Why is Type III Collagen So Crucial for Youthful Skin?

Collagen makes up about 75%–80% of the skin’s dry weight. Type I and Type III are two of the most important types for skin health. Type I collagen primarily offers structural support, making the skin firm. Type III collagen, the type that is replicated in Type III humanized collagen, provides elasticity, softness and a plumper look, thus it is also called “youth collagen” or “baby collagen”.

As we get older, the body’s ability to produce collagen slowly decreases, declining around 1% annually on average. Importantly, Type III collagen is usually lost faster than Type I. And so the skin has a little structural support but it's difficult for the skin to maintain that refined, soft, and elastic quality of youth. And so the signs of aging come—sagging, fine lines, rough texture, less ability to repair.

To delay this, traditional aesthetic medicine has mainly used two methods to increase the levels of collagen:

● Topical skincare products: Most collagen molecules won’t make it past the skin barrier and just sit on top. Their main purpose is to moisturize, not to actually replenish collagen.

● Collagen stimulators: These are things like PLLA for example, which stimulate the body to produce a mild inflammatory response, indirectly stimulating the production of its own collagen. This is the most common treatment method for collagen peptides antiaging injection available today.

But these methods have limitations. Topical products have a limited ability to penetrate the dermis, and traditional stimulators usually require multiple sessions and weeks or months to produce gradual results. Furthermore, outcomes of treatment can vary from individual to individual, as they depend on the body's own repair mechanisms and in rare cases complications such as the formation of nodules can occur.

In recent years, with the maturation of technology for recombinant human collagen in aesthetics, a new treatment concept has become popular: changing from only stimulating the body to “produce its own collagen” to directly replenishing recombinant Type III collagen, which is highly compatible with the human body. This type of regenerative collagen injection supports tissue repair and offers a bioactive environment that is very similar to natural collagen, being the future of next generation recombinant collagen lifting injections. That is exactly the idea behind OTESALY Collagen Lift product.

Introduction to Recombinant Humanized Collagen Technology

In recent years, recombinant human collagen has become one of the most promising biotechnologies in the domain of medical aesthetics. To summarize, recombinant humanized collagen is not a synthetic filler, nor is it derived from animal tissue, but rather a functional collagen – produced using modern bioengineering techniques – that closely resembles the natural collagen found in the human body.

Its production is based on gene recombination technology: scientists insert human collagen-related genes into host cells (usually yeast or microbial cells), and then produce collagen molecules through biological fermentation. As the process is not dependent on animal derived tissues, it can successfully eliminate the risk of immune reactions, batch-to-batch variability and disease transmission associated with animal sourced collagen, whilst avoiding the associated ethical issues.

This technology allows for greater purity and consistency and more stable product quality than traditional animal-derived collagen. It has thus become a key technological platform for next generation collagen based products for skin regeneration and anti-aging peptide injections

The OTESALY Collagen Lift is developed based on this technology and uses recombinant humanized collagen Type III manufactured in a biopharmaceutical production environment conforming to GMP standards. The product is of high purity, stability and batch consistency through strict quality control system, which provides reliable quality assurance for clinical applications.

Why are more clinics moving toward next generation collagen technology? Recombinant Collagen and PLLA

PLLA has long been considered the classic collagen stimulator as it pertains to collagen regenerating treatments. This leads many physicians and clinics to ask the key question: What are the differences between recombinant collagen and PLLA?

Both are aimed at skin aging and collagen regeneration but with different modes of action. PLLA is a typical collagen stimulator, mainly depending on the biological response of the body to the material, gradually stimulating fibroblasts to produce new collagen, so it often takes weeks or even months to achieve the desired results.

In contrast, recombinant humanized type III collagen not only directly supplements the skin with bioactive collagen but also serves as a scaffold for tissue repair and collagen remodeling closely mimicking the natural environment of the body. Hence, it has better effect on skin texture, elasticity and firmness in initial stages of treatment.

Recent studies have shown that the recombinant humanized collagen has a faster clinical efficacy in improving the skin condition (p < 0.001) in the early stages of treatment with a similar safety profile as PLLA in 180 days of follow-up period. Although PLLA has the advantage of long-term collagen stimulation, recombinant collagen acts faster and is less dependent on inflammatory stimulation mechanisms, giving patients a smoother and more predictable treatment experience.

This means clinics see faster patient improvement, greater treatment satisfaction and an increased probability of return visits, leading to more value for long term client management.

Conclusion：

Since the field of recombinant human collagen in aesthetics is constantly evolving, anti-aging treatments are moving from the simple “stimulation of collagen production” to a new phase of “replenishing natural collagen and promoting tissue repair.”

OTESALY Collagen Lift is an anti-sagging collagen injectable that uses modern bioengineering technology and recombinant humanized Type III collagen to give practitioners more flexibility in treatment and patients a more natural rejuvenation experience.

OTESALY is not just products for aesthetic clinics, medical beauty centers or distributors looking for wholesale partners of collagen stimulators. The company strives to build stable, long-term partnerships that allow partners to deliver professional skin rejuvenation solutions to various markets.

FAQ：

What is Type III humanized collagen?

Type III humanized collagen is a functional collagen produced using genetic recombination technology, rather than being derived from animal tissues. It bears a high degree of structural and biological similarity to natural human Type III collagen and exhibits excellent biocompatibility, stability, and batch-to-batch consistency; consequently, it is rapidly becoming a key area of development in the field of recombinant human collagen for aesthetic applications.

Is recombinant collagen safe?

Recombinant humanized collagen is not derived from animal tissues but is produced using genetic recombination technology, thereby offering superior biocompatibility and product consistency. Studies have shown that recombinant type III collagen demonstrates a favorable safety and tolerability profile when used for appropriate indications and administered by qualified medical professionals following standardized procedures. However, as with any injectable aesthetic procedure, a professional assessment prior to treatment and adherence to standardized operational protocols are recommended.

Is bioactive collagen better than regular collagen?

The mechanism of action of bioactive recombinant collagen differs from that of traditional collagen products.

Traditional animal-derived collagen is primarily used to replenish moisture in the skin's surface layers, whereas collagen stimulators—such as PLLA—work by prompting the body to produce its own collagen. In contrast, the recombinant Type III collagen used in anti-aging collagen peptide injections not only provides bioactive collagen support to the skin but also actively participates in tissue repair and collagen remodeling.

The most suitable treatment approach should be determined by a medical professional following a comprehensive assessment of the patient's skin condition, the extent of aging, and specific treatment goals.

Who is a good candidate for recombinant collagen injections?

Recombinant Type III collagen is suitable for individuals seeking to address skin laxity, fine lines, rough texture, and photoaging, as well as those looking to improve their skin barrier function; it may also be used for post-procedural skin repair based on a physician's assessment. Suitability for treatment requires a professional evaluation that takes into account the individual's specific skin condition and medical history.

How does OTESALY Collagen Lift differ from traditional PLLA stimulators?

This is the question most frequently raised by doctors and clinics, and it highlights the core difference between recombinant collagen and PLLA.

PLLA primarily relies on stimulating the body's own collagen production, meaning results often take weeks or even months to become apparent. In contrast, OTESALY Collagen Lift utilizes recombinant humanized type III collagen technology; it replenishes collagen while supporting skin repair, providing bioactive support that closely mimics the natural collagen environment.

The two are not mutually exclusive alternatives but rather represent different approaches to rejuvenation, allowing for selection based on specific indications and patient needs